Skip to content

There. You're smarter.

  • Articles
  • SmartPill
  • FastPoll
  • HealthyDose
  • Contact Us
  • About InsightCity
  • Search

stat_4-24-17

Posted on April 23, 2017Full size 600 × 210

Related

Post navigation

Previous Previous post: SmartPill™ for the Week of April 24, 2017

Sign up for our newsletter

SmartPill™ for the Week of April 16, 2018

Antidepressant prescribing:

Source: Health and Social Care Information Center via NHS Digital

  • SmartPill™ for the Week of April 16, 2018
    Antidepressant prescribing: Source: Health and […]
  • SmartPill™ for the Week of April 9, 2018
    Nightmare bacteria: Source: Centers for Disease […]
  • SmartPill™ for the Week of April 2, 2018
    Vaccinating health care workers: Source: […]
  • SmartPill™ for the Week of March 26, 2018
    Physician salaries: Source: JAMA […]
  • SmartPill™ for the Week of March 19, 2018
    RIP Stephen Hawking: Source: USA TODAY […]

FastPoll™ for the Week of April 9, 2018

Would a cancer warning label on coffee change your coffee consumption?

  • FastPoll™ for the Week of April 9, 2018
    Would a cancer warning label on coffee change your coffee consumption? […]
  • FastPoll™ for the Week of April 2, 2018
    Were you involved in an April Fool’s day prank? […]
  • FastPoll™ for the Week of March 26, 2018
    Would you describe the last meal you ate as healthy? […]
  • FastPoll™ for the Week of March 19, 2018
    If you were in the US House of Representatives (gross, right?), would you vote for the proposed […]
  • FastPoll™ for the Week of March 12, 2018
    Which better describes how you feel about Allergan’s transfer of the Restasis patent to the […]

Tags

AbbVie addiction adherence advertising Aetna alcohol allergan Alzheimer’s disease Amazon Amgen antibiotic resistance antibiotics Apple apps AstraZeneca bacteria biologics biopharma biosimilars biotech breast cancer Brexit cancer Celgene China clinical research clinical trials CRISPR data depression diabetes diet direct to consumer drug approvals drug development Drug Pricing electronic health records Eli Lilly emergency department ethics exercise FDA fitness generics gene therapy genetics GSK health healthcare healthcare costs heart disease HIV hospitals immunotherapy influenza Innovation insurance lawsuits legislation M&A malaria manufacturing marketing medical device Medicare mental health Merck Mylan NHS NICE NIH Novartis obesity oncology opioids orphan drugs patients pfizer pharma pharmacy Phase I physicians prescriptions pricing public health regulation regulatory research Sanofi sleep smoking social media stem cells stroke technology Teva Trump UK vaccines wearables weight loss WHO youth zika

Sign up for updates

Contact us

[email protected] | 919-230-6767
Theme: Maisha Lite designed by Anariel Design.